185 related articles for article (PubMed ID: 7975491)
1. Kill and cure. The hope and reality of virus inactivation.
Prowse C
Vox Sang; 1994; 67 Suppl 3():191-6. PubMed ID: 7975491
[No Abstract] [Full Text] [Related]
2. Virus inactivation of fresh plasma.
Mohr H
Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
[No Abstract] [Full Text] [Related]
3. [Virus in hemophilia: current status and future perspectives].
Aguilar C; Félix Lucía J
Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
[No Abstract] [Full Text] [Related]
4. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma.
Wagner SJ; Friedman LI; Dodd RY
Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274
[No Abstract] [Full Text] [Related]
5. Photodynamic virus inactivation of blood components.
Mohr H; Lambrecht B; Selz A
Immunol Invest; 1995; 24(1-2):73-85. PubMed ID: 7713607
[No Abstract] [Full Text] [Related]
6. [Viral safety considerations in immunoglobulin preparations].
Gómez Manzano P; Escrivá CA; Salmerón García F; Alonso Verduras C
Sangre (Barc); 1997 Jun; 42(3):199-203. PubMed ID: 9381262
[No Abstract] [Full Text] [Related]
7. Inactivation of viruses in blood and plasma products.
Suomela H
Transfus Med Rev; 1993 Jan; 7(1):42-57. PubMed ID: 8431658
[No Abstract] [Full Text] [Related]
8. Reducing the residual risk of transfusion-transmitted viruses: mini-pool or single-donation NAT?
Roth WK; Seifried E
Transfusion; 2001 Jun; 41(6):845-7. PubMed ID: 11399831
[No Abstract] [Full Text] [Related]
9. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
[TBL] [Abstract][Full Text] [Related]
10. Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment.
Smith MP; Rice KM; Savidge GF
Thromb Haemost; 1997 Feb; 77(2):406-7. PubMed ID: 9157608
[No Abstract] [Full Text] [Related]
11. [Viral safety measures of plasma for transfusion and applicability in Spain].
Pereira A
Med Clin (Barc); 2007 Oct; 129(12):458-68. PubMed ID: 17953912
[No Abstract] [Full Text] [Related]
12. Genomic screening for blood-borne viruses in transfusion settings.
Lee HH; Allain JP
Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
[No Abstract] [Full Text] [Related]
13. Strategies for reducing the exposure to donor blood.
Murphy M
Clin Med (Lond); 2005; 5(4):337-40. PubMed ID: 16138487
[No Abstract] [Full Text] [Related]
14. Inactivation of viruses found with plasma proteins.
Horowitz B
Biotechnology; 1991; 19():417-30. PubMed ID: 1786476
[TBL] [Abstract][Full Text] [Related]
15. Virus inactivation in blood components by photoactive phenothiazine dyes.
Wagner SJ
Transfus Med Rev; 2002 Jan; 16(1):61-6. PubMed ID: 11788930
[TBL] [Abstract][Full Text] [Related]
16. Virus validation experiments on the production process of OCTAVI SDPlus.
Biesert L; Lemon S; Suhartono H; Wang L; Rübsamen H
Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S48-54. PubMed ID: 7495968
[TBL] [Abstract][Full Text] [Related]
17. A solvent I detergent treated, pasteurised and highly purified factor VIII concentrate.
Schwinn H; Stadler M; Josic D; Bal F; Gehringer W; Nur I; Schütz R
Arzneimittelforschung; 1994 Feb; 44(2):188-91. PubMed ID: 8147954
[TBL] [Abstract][Full Text] [Related]
18. Photoinactivation of viruses and cells for medical applications.
Corash L; Hanson CV
Blood Cells; 1992; 18(1):3-5. PubMed ID: 1617191
[No Abstract] [Full Text] [Related]
19. [Viral safety of hemoderivatives: in search of zero risk].
Hernández JM; Tusell JM
Sangre (Barc); 1996 Apr; 41(2):97-100. PubMed ID: 9045365
[No Abstract] [Full Text] [Related]
20. The role of leukodepletion in the control of transfusion-transmitted disease.
Goldman M; Delage G
Transfus Med Rev; 1995 Jan; 9(1):9-19. PubMed ID: 7719040
[No Abstract] [Full Text] [Related]
[Next] [New Search]